Bio Pharma Dive
NOVEMBER 8, 2021
Study results for Mirati's drug combined with Keytruda have been much anticipated, as the San Diego biotech aims to challenge Amgen and its rival KRAS-blocking drug Lumakras.
pharmaphorum
NOVEMBER 8, 2021
The UK government has announced £248 million in spending over the next year for a project to make it easier for patient test results and scans to be shared between hospitals, labs and GP surgeries. The aim is to “digitise diagnostics care” across the NHS, reducing the time it takes to diagnose health problems and get treatment started earlier, helping to address the massive backlog in care caused by the pandemic, according to a Department of Health and Social Care (DHSC) statement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 8, 2021
Shortly after postponing a $135 million IPO, Gyroscope has found another way to back a treatment for a disease that's become a top target of multiple drugmakers.
BioSpace
NOVEMBER 8, 2021
Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes and insulin resistance.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
NOVEMBER 8, 2021
Alongside the milestone, the gene editing biotech also announced John Maraganore, who's soon to step down as Alnylam's CEO, will join its board.
BioSpace
NOVEMBER 8, 2021
AstraZeneca announced its plans to create a new, separate division for vaccines and antibody therapies, specifically its COVID-19 vaccine developed with the University of Oxford and other COVID-19 antibody treatments.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
NOVEMBER 8, 2021
After co-developing one of the world’s most widely used COVID-19 vaccines, Pfizer announced positive trial results on Friday for its investigational antiviral pill, revealing that the pill could cut the risk of hospitalization and death by 89 percent. The drug, called Paxlovid (a combination of PF-07321332 and ritonavir), is among the first orally administered antivirals against SARS-CoV-2, as other authorized or approved antivirals, such as remdesivir, are administered through intravenous (IV)
Bio Pharma Dive
NOVEMBER 8, 2021
This year, the pharmaceutical industry will spend more on its promotional activities than any year before. It’s estimated that the total U.S. promotional spend for 2021 will be around $30 billion.
Intouch Solutions
NOVEMBER 8, 2021
“Craft matters, and it is the next frontier in our industry,” says Intouch chief creative officer Susan Perlbachs. “We have a responsibility to elevate our work and to make it un-ignorable, so that vital messages can do their job.”. Fortunately, craft is something we’re brimming with at Intouch, and our latest campaign — which symbolizes our unique approach to solving client challenges in creative ways others can’t imagine — dials it up to eleven.
Bio Pharma Dive
NOVEMBER 8, 2021
The COVID-19 pandemic emerged at a time when the clinical trial landscape had reached a peak in complexity. Global trials are now commonplace as drug makers seek to establish efficacy in diverse populations.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
NOVEMBER 8, 2021
GTFO It’s Vegan has announced the launch of its own line of vegan sashimi. The company is an online retailer, distributor and wholesaler of all things vegan. Some popular categories on their website include cheese, meat and seafood. The line of vegan sashimi includes tuna, salmon, sailfish and calamari. The products are available for purchase on GTFO It’s Vegan’s website.
Bio Pharma Dive
NOVEMBER 8, 2021
Set yourself up for successful audits and inspections with the Connected Workplace.
Pharma Times
NOVEMBER 8, 2021
Daprodustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development for anaemia due to chronic kidney disease
BioSpace
NOVEMBER 8, 2021
DeepCure announced the closing of its $40 million Series A financing round. The round, led by Morningside Ventures, brings the company’s total amount raised to $47 million since it was founded in 2018.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioPharma Reporter
NOVEMBER 8, 2021
Novavax has completed its rolling submission to the World Health Organization for emergency use listing (EUL) of NVX-CoV2373, its COVID-19 vaccine candidate.
BioSpace
NOVEMBER 8, 2021
Arbor announced an oversubscribed Series B raise totaling $215 million, a significant increase from their initial $15.6 milllion Series A round to test for liver and CNS diseases.
Scienmag
NOVEMBER 8, 2021
Orlando, Fla – Due to the COVID-19 pandemic, 2020 was the deadliest year on record for drug overdoses, with more than 93,000 deaths in the U.S. For too many, addiction begins in the hospital, where opioids are widely prescribed after surgeries or injuries. A new national survey by Orlando Health finds nearly four out of […].
BioSpace
NOVEMBER 8, 2021
Biohaven and Pfizer have partnered to market the Connecticut-based company’s migraine drug Nurtec ODT (rimegepant) outside the U. S. once approved by global regulatory organizations.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
NOVEMBER 8, 2021
WASHINGTON (Nov. 8, 2021) — A new study published today reveals systematic biases among primary and HIV care providers about people who inject drugs and how those biases may impact access to pre-exposure prophylaxis (PrEP), a preventive, prescription-based medication that significantly reduces the risk of HIV infection through sexual behavior and injection practices.
BioSpace
NOVEMBER 8, 2021
Shares of Xencor, Inc. are down nearly 6% after the company announced Novartis terminated its rights to develop vibecotamab, a CD123 x CD3 blood cancer bispecific.
Scienmag
NOVEMBER 8, 2021
HOUSTON, Nov. 8, 2021 – The American Pediatric Society (APS) is pleased to announce Megan A. Moreno, MD, MSEd, MPH, as the recipient of the 2022 Norman J. Siegel Outstanding Science Award for her considerable contributions to pediatric science. The award will be presented to Dr. Moreno during the APS Presidential Plenary at the Pediatric Academic Societies […].
BioSpace
NOVEMBER 8, 2021
New studies come out regularly supporting the efficacy and safety of the COVID-19 vaccines. Here’s a look as well as other COVID-19 news.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
NOVEMBER 8, 2021
Over the past 18 months of news reporting and popular discussion, the phrase “global supply chain” has been as prominent as it has ever been. Credit: courtesy Lehigh University Over the past 18 months of news reporting and popular discussion, the phrase “global supply chain” has been as prominent as it has ever been. Pandemic-borne […].
Pharma Times
NOVEMBER 8, 2021
Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis
Scienmag
NOVEMBER 8, 2021
The membranes of cancer cells are more pliant than the membranes of normal cells. A research collaboration has discovered that cancer invasion and migration can be supressed in mice by manipulating the stiffness of the cell membrane. The research group included Lecturer TSUJITA Kazuya and Professor ITOH Toshiki, both of Kobe University’s Biosignal Research Center, […].
BioSpace
NOVEMBER 8, 2021
Alltrna, based in Cambridge, Mass. near its cousin Moderna, debuts as the first platform transfer RNA (tRNA) company.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
NOVEMBER 8, 2021
A new study, co-authored by researchers at the Wildlife Conservation Society (WCS) and the University of British Columbia’s Faculty of Forestry, offers a “scorecard” for climate adaptation projects – a set of 16 criteria that can be used to evaluate climate adaptation projects and inform their design. The scientists recently published their findings in the […].
Pharma Times
NOVEMBER 8, 2021
Detailed results from the CheckMate-816 trial will be shared at an upcoming medical conference
Scienmag
NOVEMBER 8, 2021
Credit: John Innes Centre A gene which has profound effects on the production of seeds has been identified by researchers from the John Innes Centre. Gene-editing techniques helped to identify and explain the key gene, ZIP4, in wheat which is responsible for maintaining 50% of yield in this global crop. The discovery presents […].
Pharma Marketing Network
NOVEMBER 8, 2021
November 3, 2021 – Tune in with the Pharma Marketing Network for an exciting conversation with R.J. Lewis and David Hunt, CEO of The Considered, as he shares how his new independent agency, The Considered, about how they are breaking the rules in pharma advertising. David discusses and answers questions around: How The Considered is different. What launched the conception of the agency?
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
341 
Let's personalize your content